Abiopharma

News list

SVF Pauling (Cayman) Ltd 🔴 sold 6.0M shares of Relay Therapeutics, Inc. (RLAY) at $19.40 ($116.4M) Transaction Date: Aug 25, 2026 | Filing ID: 040513

Full text

News bot Aug. 28, 2026, 1:02 p.m.
🔍 SVF Pauling (Cayman) Ltd (Executive)

Company: Relay Therapeutics, Inc. (RLAY)

Report Date: 2026-08-25
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 6,000,000
Detailed Transactions and Holdings:
- Sold 6,000,000 shares of Common Stock at $19.4 per share (Direct)
  Date: 2026-08-25 | Code: S | equity_swap_involved: 0 | shares_owned_after: 21,904,963.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Securities held of record by SVF Pauling (Cayman) Limited, a wholly owned subsidiary of SoftBank Vision Fund (AIV M2) L.P. ("AIV M2"). SB Investment Advisers (UK) Limited ("SBIA UK") has been appointed as alternative investment fund manager ("AIFM") and is exclusively responsible for managing AIV M2 in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As AIFM of AIV M2, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF Pauling (Cayman) Limited's investments.